Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,165.52
(0.46%)
USD/AUD
0.62
0.07%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,021.77
(0.37%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,165.52
(0.46%)
USD/AUD
0.62
0.07%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,021.77
(0.37%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,165.52
(0.46%)
USD/AUD
0.62
0.07%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,021.77
(0.37%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,165.52
(0.46%)
USD/AUD
0.62
0.07%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,021.77
(0.37%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,165.52
(0.46%)
USD/AUD
0.62
0.07%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,021.77
(0.37%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,165.52
(0.46%)
USD/AUD
0.62
0.07%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,021.77
(0.37%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,165.52
(0.46%)
USD/AUD
0.62
0.07%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,021.77
(0.37%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,165.52
(0.46%)
USD/AUD
0.62
0.07%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,021.77
(0.37%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,165.52
(0.46%)
USD/AUD
0.62
0.07%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,021.77
(0.37%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,165.52
(0.46%)
USD/AUD
0.62
0.07%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,021.77
(0.37%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,165.52
(0.46%)
USD/AUD
0.62
0.07%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,021.77
(0.37%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,165.52
(0.46%)
USD/AUD
0.62
0.07%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,021.77
(0.37%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,165.52
(0.46%)
USD/AUD
0.62
0.07%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,021.77
(0.37%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,165.52
(0.46%)
USD/AUD
0.62
0.07%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,021.77
(0.37%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,165.52
(0.46%)
USD/AUD
0.62
0.07%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,021.77
(0.37%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,165.52
(0.46%)
USD/AUD
0.62
0.07%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,021.77
(0.37%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,165.52
(0.46%)
USD/AUD
0.62
0.07%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,021.77
(0.37%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,165.52
(0.46%)
USD/AUD
0.62
0.07%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,021.77
(0.37%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,165.52
(0.46%)
USD/AUD
0.62
0.07%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,021.77
(0.37%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.25
(0.04%)
Lithium
42.74
1.28%
Gold
2,633.50
0.16%
Copper
4.10
0.2%
Oil
70.17
0.88%
Bitcoin
98,165.52
(0.46%)
USD/AUD
0.62
0.07%
FTSE 100
8,137.00
0.42%
Nikkei 225
39,021.77
(0.37%)
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%

Lumos Diagnostics (ASX: $LDX) secures US approval for FebriDx reimbursement

Introduction to Lumos Diagnostics' US milestone


Lumos Diagnostics (ASX:LDX), a leader in rapid point-of-care diagnostics, has achieved a pivotal milestone with the approval of a new CPT PLA procedure code for its FebriDx test in the United States. The Centers for Medicare and Medicaid Services (CMS) has set a reimbursement rate of $41.38 per test, effective January 1, 2025. This approval is expected to enhance accessibility and adoption of FebriDx, facilitating reimbursement from both government and private insurers.

Summary of Lumos Diagnostics' strategic advancement


Lumos Diagnostics has secured a significant milestone with the approval of a new CPT PLA procedure code for its FebriDx test in the US, with a reimbursement rate set by CMS at $41.38 per test. This development is expected to improve the accessibility and adoption of FebriDx, a test capable of distinguishing between bacterial and non-bacterial infections at the point of care, addressing antibiotic overprescription issues. The company plans to engage with US payers to establish comprehensive reimbursement policies and aims to achieve CLIA waiver labeling for further market reach. This aligns with Lumos Diagnostics' strategy to expand its portfolio of diagnostic solutions and address public health challenges, such as antibiotic resistance.

Executive insights on FebriDx's US approval


The approval of the PLA code is a crucial step in the U.S. commercialization of FebriDx and an advancement toward removing access barriers.

LUMOS DIAGNOSTICS HOLDINGS LIMITED
LDX | ASX | Health Care
0.0366.9388939039072E-18(+0%)
At close 24/12 (AEDT)
Market cap
$26.9M
Volume
13,700
DY Yield
PE Ratio
52 Week Range
0.028 - 0.1075
1YR Return
N / A

0 Comments
Inline Feedbacks
View all comments
Social Media Auto Publish Powered By : XYZScripts.com

Stock Piper AI Index Coming Soon!

Join our Newsletter to gain exclusive insight and be notified once we are live.

By clicking Subscribe, you agree to our Terms & Conditions

ASX News, First And Fast.

Get all the latest market updates straight to your inbox.

By clicking Subscribe, you agree to our Terms & Conditions